Health Canada says no evidence of cardiac risk from Nexium, not clear for Losec

From the Canadian Press:
Health Canada says it finds no evidence to suggest a popular heartburn drug increases the risk of cardiac problems.

The department says it will continue to monitor safety data for Nexium (esomeprazole) as it is produced, but at this point does not see a link between the drug and cardiovascular risks.

But the department says the picture is less clear for another heartburn drug, Losec (omeprazole).

It says after a thorough analysis, Health Canada cannot definitively say if there is a potential for increased cardiovascular risk in people taking the drug on a long-term basis. ...more

Health Canada investigates Losec, Nexium for heart risks

From CBC News:
Health Canada is alerting consumers who take Losec and Nexium, two prescription medications primarily used to treat acid-related stomach disorders, that it is investigating the drugs' links to serious cardiac problems.

Studies of the two medications reveal that patients using Losec or Nexium to treat gastroesophageal reflux disease (GERD) instead of surgery "may have experienced more heart attacks or cardiac deaths than patients who had the surgery," reads the advisory.

It also notes that many patients who developed cardiac problems had risk factors prior to beginning treatment. ...more